Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Abiomed; Amgen; AstraZenca; Bayer AG; Bbraun; Biotronik; Boehringer Ingelheim; Boston Scientific Corporation; Bristol-Myers Squibb; Edwards Lifesciences; Fumedica; Guerbet; Janssen Pharmaceuticals; Medalliance; Medtronic; Novartis; Pfizer; Sanofi Aventis; Servier; sinomed; Cordis Corporation, a Johnson & Johnson company; Corflow Therapeutics; CSL Behring; Daiichi-Sankyo/Elil Lilly and Company; Johnson&Johnson; V-Wave; Abbott; GE Healthcare; Inari Medical; Novo Nordisk; Philips; Siemens Healthcare; SMT; MSD Merck Sharp&Dohm; Amicus Therapeutics; Bioanalytica; IACULIS; Neovii Pharmaceutica; Neutromedics AG; OM Pharma; Optimapharm; Orchestra BioMed; Shockwave Medical; Vascular Medical</li></ul>